ARK Investment Management IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 20 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

ARK Investment Management ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2022$19,816
-60.8%
2,935,679
-3.4%
0.12%
-44.5%
Q1 2022$50,573
-63.2%
3,037,443
-57.8%
0.21%
-49.3%
Q4 2021$137,477
-52.1%
7,201,518
-38.2%
0.42%
-39.7%
Q3 2021$287,285
-40.2%
11,649,837
-36.9%
0.69%
-22.7%
Q2 2021$480,088
-23.1%
18,450,713
-6.5%
0.89%
-28.0%
Q1 2021$624,546
-12.0%
19,726,650
+29.0%
1.24%
-34.3%
Q4 2020$709,819
+172.8%
15,297,822
+93.6%
1.89%
+22.4%
Q3 2020$260,177
+123.8%
7,903,308
+86.6%
1.54%
+23.4%
Q2 2020$116,258
+337.8%
4,235,273
+377.4%
1.25%
+88.8%
Q1 2020$26,558
+16.5%
887,179
+7.8%
0.66%
+15.1%
Q4 2019$22,790
+53.7%
823,344
+1.0%
0.58%
+77.5%
Q3 2019$14,829
-25.1%
814,796
+0.9%
0.32%
-35.1%
Q2 2019$19,805
+201.2%
807,688
+16.8%
0.50%
+165.4%
Q1 2019$6,576
+2.3%
691,494
-4.8%
0.19%
-28.0%
Q4 2018$6,428
+34.5%
726,360
+71.0%
0.26%
+81.2%
Q3 2018$4,779
+204.4%
424,820
+246.4%
0.14%
+148.3%
Q2 2018$1,570
+42.7%
122,623
+88.4%
0.06%
+5.5%
Q1 2018$1,10065,0960.06%